{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-335109","form_type":"8-K","ticker":"MYO","cik":"0001369290","company_name":"MYOMO, INC.","filed_at":"2026-08-05T20:10:26+00:00","discovered_at":"2026-08-05T20:12:30.200370+00:00","generated_at":"2026-08-05T20:13:11.091324+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Myomo Q2 revenue $11.7M (+21% YoY); raises FY guidance to $45-47M","bullets":["Revenue $11.7M, up 21% YoY; gross margin 72.1% vs 62.7% last year.","Net loss $4.0M ($0.09/share) includes $1.2M non-cash derivative mark; operating loss improved to $2.3M from $4.6M.","Adjusted EBITDA loss improved 79% to $0.8M from $4.0M.","Record 255 orders in Q2 (+23% YoY); 53% of revenue from recurring patient sources (up from 26%).","Raises FY 2026 revenue guidance to $45-47M; Q3 guidance $11.5-12.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-335109","json":"https://secwatch.observer/filing/0001193125-26-335109.json","markdown":"https://secwatch.observer/filing/0001193125-26-335109.md","text":"https://secwatch.observer/filing/0001193125-26-335109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369290/000119312526335109/0001193125-26-335109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369290/000119312526335109/myo-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:13:11.091324+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}